ENDRA Life Sciences Inc. Common Stock (NDRA)
Stock · NASDAQ · Health Care
$4.9as of 10/16/2026
Price chart
Active signals
NDRA Signal Track Record
How signals performed across all stocks →What NDRA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 21 | -5.1% | 38% | September 16, 2026 |
| Bollinger Band Breakout | 21 | -16.3% | 33% | August 26, 2026 |
| Bollinger Band Breakdown | 15 | -9.1% | 40% | June 5, 2026 |
| 200-Day Moving Average TouchActive now | 9 | +7.6% | 67% | August 25, 2026 |
| Any 20-session window (baseline) | -7.4% | 37% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NDRA
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as…
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Employees
- 9
- Website
- www.endrainc.com/
Fundamentals
- 1-day range
- $4.78$5
- Market cap
- $5.68M
- P/E (trailing)
- —
- P/E (forward)
- -1.60
- EPS (trailing)
- $-5.98
- Dividend yield
- —
- Beta
- -0.17
- Avg. volume
- 32.3K
How ENDRA Life Sciences Inc. Common Stock Makes Money
Where the revenue actually goes — FY2018 annual results
Source: 10-K filed Mar 11, 2019 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
ENDRA Life Sciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- NDRAENDRA Life Sciences Inc. Common Stock$4.74▼ 7.06%Market cap $5.68MP/E —$2.96$8
- NUWENuwellis Inc. Common Stock$0.55▲ 0.00%Market cap $5.26MP/E 0.03$0.4444$172.9
- ITOCiTonic Holdings Ltd Class A Ordinary Shares$3.84▼ 4.24%Market cap $4.94MP/E —$3.51$18.4
- NXLNexalin Technology Inc. Common Stock$2.35▼ 4.08%Market cap $7.45MP/E —$2.38$50.7
- VBIOValion Bio Inc. Common Stock$1.17▼ 4.88%Market cap $1.14MP/E —$1.11$32.5
- IRIXIRIDEX Corporation Common Stock$0.81▼ 1.22%Market cap $14.61MP/E —$0.607$1.65
- QTIQT Imaging Holdings Inc. Common Stock$2.4▲ 0.84%Market cap $37.38MP/E —$2.38$19.05
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NDRA ENDRA Life Sciences Inc. Common Stock | $5.68M | — | $4.74 | ▼ 7.06% | $2.96$8 |
| NUWE Nuwellis Inc. Common Stock | $5.26M | 0.03 | $0.55 | ▲ 0.00% | $0.4444$172.9 |
| ITOC iTonic Holdings Ltd Class A Ordinary Shares | $4.94M | — | $3.84 | ▼ 4.24% | $3.51$18.4 |
| NXL Nexalin Technology Inc. Common Stock | $7.45M | — | $2.35 | ▼ 4.08% | $2.38$50.7 |
| VBIO Valion Bio Inc. Common Stock | $1.14M | — | $1.17 | ▼ 4.88% | $1.11$32.5 |
| IRIX IRIDEX Corporation Common Stock | $14.61M | — | $0.81 | ▼ 1.22% | $0.607$1.65 |
| QTI QT Imaging Holdings Inc. Common Stock | $37.38M | — | $2.4 | ▲ 0.84% | $2.38$19.05 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 79.5K
- Total value held
- $369.7K
- Institutional holders
- 7
- Unknown51.9K
- Unknown21.1K
- Unknown3.5K
- Unknown2.8K
- Unknown152
- Unknown19
- Unknown4
See the full, filterable feed with live charts on the MarketWall dashboard.